VCEL - Vericel Corp Ord logo

Vericel Corp Ord

VCEL

Vericel Corporation develops and commercializes cellular therapies and specialty biologics, focusing on sports medicine and severe burn care. Its key products include MACI for knee cartilage repair, Epicel for burn treatment, and NexoBrid for eschar removal.

โš•๏ธ Healthcare NASDAQ Listed 1997 $ USD
$1,000 invested 20 years ago โ†’$217today

Score Overview

1 Year
Score
Net Growth46.63%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth10.88%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score8.2
Net Growth424.20%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth96.12%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth223.79%
Net Trend70%
Net Income Consistency
Rev Growth463.23%
Rev TrendEvery year
Revenue Consistency
20 Years
Score4.6
Net Growth247.02%
Net Trend50%
Net Income Consistency
Rev Growth354x
Rev Trend72%
Revenue Consistency
All Time
Score
Net Growth269.38%
Net Trend45%
Net Income Consistency
Rev Growth765x
Rev Trend59%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Vericel Corp Ord has ranked, year by year

Measure
Fundamentals Window

Showing 5 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • VCEL

2003: 61.4% ยท 2021: 25.2% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 40.24โ€”
1 Year2025-09-26
$ 30.2333.11%
5 Years2021-09-28
$ 48.15-16.43%
10 Years2016-09-28
$ 2.9513x
20 Years2006-09-28
$ 185.60-78.32%
All Time1997-02-04
$ 1.12K-96.41%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 306M$ 24M$ 162M
2025$ 276M$ 16M$ 137M
2024$ 237M$ 10M$ 116M
2023$ 197M-$ 3M$ 109M
2022$ 164M-$ 16M$ 119M
2021$ 156M-$ 7M$ 103M
2020$ 124M$ 2M$ 75M
2019$ 117M-$ 9M$ 69M
2018$ 90M-$ 8M$ 82M
2017$ 63M-$ 17M$ 26M
2016$ 54M-$ 19M$ 22M
2015$ 51M-$ 16M$ 14M
2014$ 28M-$ 19M$ 30M
2013-$ 15M$ 8M
2012$ 21K-$ 29M$ 13M
2011$ 18K-$ 19M$ 5M
2010$ 89K-$ 17M$ 31M
2009$ 182K-$ 15M$ 17M
2008$ 522K-$ 20M$ 22M
2007$ 685K-$ 17M$ 28M
2006$ 863K-$ 16M$ 42M
2005$ 909K-$ 11M$ 32M
2004$ 1M-$ 10M$ 16M
2003$ 844K-$ 9M$ 10M
2002$ 877K-$ 7M$ 9M
2001$ 899K-$ 5M$ 10M
2000$ 1M-$ 9M$ 12M
1999$ 881K-$ 11M$ 7M
1998$ 249K-$ 17M$ 11M
IPO1997$ 400K-$ 14M$ 19M
VCEL - Vericel Corp Ord logo

Vericel Corp Ord fundamental performance

Between 2020 and 2025, revenue grew from $ 124M to $ 276M and net income grew from $ 2M to $ 16M. Revenue increased in every one of those 5 years; net income in 4.

Between 2015 and 2025, revenue grew from $ 51M to $ 276M and net income went from -$ 16M to $ 16M. Revenue increased in every one of those 10 years; net income in 7.

Vericel Corp Ord currently holds a 20-year HDB Score of 4.6 out of 10. How the HDB Score is calculated.

Membership

Continue VCELโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies